{"hands_on_practices": [{"introduction": "The journey of rational drug design often begins with a fundamental question: how strongly does a potential drug bind to its target? This practice bridges the gap between kinetics (the rates of binding and unbinding) and thermodynamics (the overall stability of the drug-target complex). By working with experimental rate constants, you will calculate key metrics like the dissociation constant ($K_d$) and the Gibbs free energy of binding ($\\Delta G^{\\circ}$), which are the universal currency for quantifying and comparing drug potency [@problem_id:4985174].", "problem": "A medicinal chemistry team is optimizing a ligand for a kinase target using rational drug design principles. Surface Plasmon Resonance (SPR) measurements report a bimolecular association rate constant $k_{\\mathrm{on}} = 1 \\times 10^{6}\\ \\mathrm{M^{-1}\\,s^{-1}}$ and a unimolecular dissociation rate constant $k_{\\mathrm{off}} = 0.01\\ \\mathrm{s^{-1}}$ for the ligandâ€“kinase interaction at temperature $T = 298\\ \\mathrm{K}$. Using equilibrium thermodynamics and mass-action kinetics as your foundational starting point, determine the equilibrium dissociation constant $K_d$, the standard Gibbs free energy change of binding $\\Delta G^{\\circ}$, and the residence time (mean bound lifetime) of the complex. Use the gas constant $R = 1.987 \\times 10^{-3}\\ \\mathrm{kcal\\,mol^{-1}\\,K^{-1}}$. \n\nExpress $K_d$ in $\\mathrm{M}$, $\\Delta G^{\\circ}$ in $\\mathrm{kcal\\,mol^{-1}}$, and residence time in $\\mathrm{s}$. Round each of your numerical results to four significant figures. Provide your final numerical answers in the order $\\left(K_d,\\ \\Delta G^{\\circ},\\ \\text{residence time}\\right)$.", "solution": "The problem statement is subjected to validation before proceeding with a solution.\n\n### Step 1: Extract Givens\n-   Bimolecular association rate constant, $k_{\\mathrm{on}} = 1 \\times 10^{6}\\ \\mathrm{M^{-1}\\,s^{-1}}$.\n-   Unimolecular dissociation rate constant, $k_{\\mathrm{off}} = 0.01\\ \\mathrm{s^{-1}}$.\n-   Temperature, $T = 298\\ \\mathrm{K}$.\n-   Gas constant, $R = 1.987 \\times 10^{-3}\\ \\mathrm{kcal\\,mol^{-1}\\,K^{-1}}$.\n-   Quantities to determine: Equilibrium dissociation constant $K_d$, standard Gibbs free energy change of binding $\\Delta G^{\\circ}$, and residence time.\n-   Required units and precision: $K_d$ in $\\mathrm{M}$, $\\Delta G^{\\circ}$ in $\\mathrm{kcal\\,mol^{-1}}$, and residence time in $\\mathrm{s}$, with all results rounded to four significant figures.\n\n### Step 2: Validate Using Extracted Givens\n1.  **Scientifically Grounded**: The problem is based on the fundamental principles of mass-action kinetics and equilibrium thermodynamics as applied to receptor-ligand interactions, a core concept in pharmacology and medicinal chemistry. The given kinetic constants are physically realistic for typical drug-target systems.\n2.  **Well-Posed**: The problem is self-contained and provides all necessary data ($k_{\\mathrm{on}}$, $k_{\\mathrm{off}}$, $T$, $R$) to compute the three requested quantities ($K_d$, $\\Delta G^{\\circ}$, residence time). The relationships between these quantities are well-defined in physical chemistry.\n3.  **Objective**: The problem is stated using precise, unambiguous scientific language and quantitative data. It is free of subjective or opinion-based claims.\n4.  **Consistency and Feasibility**: The data are dimensionally consistent and the values are within a plausible range for biomolecular interactions. The setup is scientifically sound and does not violate any physical laws.\n\n### Step 3: Verdict and Action\nThe problem is valid as it is scientifically grounded, well-posed, objective, and internally consistent. A full solution will be provided.\n\n### Solution Derivation\nThe analysis proceeds by applying the principles of chemical kinetics and thermodynamics to the given biomolecular interaction.\n\n1.  **Determination of the Equilibrium Dissociation Constant ($K_d$)**\n    The interaction between the ligand ($L$) and the kinase target ($P$) to form the complex ($LP$) can be represented by the reversible reaction:\n    $$L + P \\underset{k_{\\mathrm{off}}}{\\stackrel{k_{\\mathrm{on}}}{\\rightleftharpoons}} LP$$\n    The rate of association is given by the law of mass action as $v_{\\mathrm{on}} = k_{\\mathrm{on}}[L][P]$, and the rate of dissociation is $v_{\\mathrm{off}} = k_{\\mathrm{off}}[LP]$.\n    At equilibrium, the rate of association equals the rate of dissociation:\n    $$k_{\\mathrm{on}}[L][P] = k_{\\mathrm{off}}[LP]$$\n    The equilibrium dissociation constant, $K_d$, is defined by the equilibrium concentrations:\n    $$K_d = \\frac{[L][P]}{[LP]}$$\n    By rearranging the rate balance equation, we can express $K_d$ in terms of the rate constants:\n    $$K_d = \\frac{k_{\\mathrm{off}}}{k_{\\mathrm{on}}}$$\n    Substituting the given values:\n    $$K_d = \\frac{0.01\\ \\mathrm{s^{-1}}}{1 \\times 10^{6}\\ \\mathrm{M^{-1}\\,s^{-1}}} = 1 \\times 10^{-8}\\ \\mathrm{M}$$\n    Rounding to four significant figures, we get $K_d = 1.000 \\times 10^{-8}\\ \\mathrm{M}$.\n\n2.  **Determination of the Standard Gibbs Free Energy Change ($\\Delta G^{\\circ}$)**\n    The standard Gibbs free energy change of binding, $\\Delta G^{\\circ}$, is related to the equilibrium constant of the association reaction. The equilibrium association constant, $K_a$, is the reciprocal of the dissociation constant, $K_d$:\n    $$K_a = \\frac{1}{K_d}$$\n    The fundamental thermodynamic relationship is:\n    $$\\Delta G^{\\circ} = -RT \\ln K_a$$\n    where the standard state for solutes is typically $1\\ \\mathrm{M}$. Substituting $K_a = 1/K_d$ into the equation yields:\n    $$\\Delta G^{\\circ} = -RT \\ln\\left(\\frac{1}{K_d}\\right) = RT \\ln K_d$$\n    For this calculation, $K_d$ must be a dimensionless quantity, which is achieved by dividing it by the standard state concentration $c^{\\circ} = 1\\ \\mathrm{M}$. The expression is formally $\\Delta G^{\\circ} = RT \\ln(K_d/c^{\\circ})$. Since $c^{\\circ}$ has a numerical value of $1$, we can proceed using the numerical value of $K_d$ expressed in molarity.\n    Substituting the known values:\n    $$R = 1.987 \\times 10^{-3}\\ \\mathrm{kcal\\,mol^{-1}\\,K^{-1}}$$\n    $$T = 298\\ \\mathrm{K}$$\n    $$K_d = 1 \\times 10^{-8}$$\n    $$\\Delta G^{\\circ} = (1.987 \\times 10^{-3}\\ \\mathrm{kcal\\,mol^{-1}\\,K^{-1}}) \\times (298\\ \\mathrm{K}) \\times \\ln(1 \\times 10^{-8})$$\n    $$\\Delta G^{\\circ} \\approx (0.592126\\ \\mathrm{kcal\\,mol^{-1}}) \\times (-18.42068)$$\n    $$\\Delta G^{\\circ} \\approx -10.90753\\ \\mathrm{kcal\\,mol^{-1}}$$\n    Rounding the result to four significant figures gives $\\Delta G^{\\circ} = -10.91\\ \\mathrm{kcal\\,mol^{-1}}$. The negative sign indicates that the binding process is spontaneous under standard conditions.\n\n3.  **Determination of the Residence Time ($\\tau$)**\n    The residence time of the complex is the average lifetime of the bound state before it dissociates. The dissociation is a unimolecular, first-order kinetic process governed by the rate constant $k_{\\mathrm{off}}$. The concentration of the complex $[LP]$ decays over time $t$ according to the first-order rate law:\n    $$[LP](t) = [LP]_0 \\exp(-k_{\\mathrm{off}} t)$$\n    The mean lifetime, or residence time $\\tau$, for a first-order decay process is the reciprocal of the rate constant:\n    $$\\tau = \\frac{1}{k_{\\mathrm{off}}}$$\n    Substituting the given value for $k_{\\mathrm{off}}$:\n    $$\\tau = \\frac{1}{0.01\\ \\mathrm{s^{-1}}} = 100\\ \\mathrm{s}$$\n    To express this to four significant figures, we write $\\tau = 100.0\\ \\mathrm{s}$.", "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n1.000 \\times 10^{-8}  -10.91  100.0\n\\end{pmatrix}\n}\n$$", "id": "4985174"}, {"introduction": "Beyond knowing the strength of a drug's binding, it is crucial to understand the energetic forces driving the interaction. This exercise delves into the thermodynamic signature of binding by applying the fundamental Gibbs free energy equation, $\\Delta G^{\\circ} = \\Delta H^{\\circ} - T\\Delta S^{\\circ}$. You will learn how to dissect the overall binding affinity into its enthalpic ($\\Delta H^{\\circ}$) and entropic ($\\Delta S^{\\circ}$) components, revealing whether binding is primarily driven by favorable interactions like hydrogen bonds or by effects like the release of water molecules [@problem_id:4985168].", "problem": "A medicinal chemistry team is characterizing a lead compound binding to its protein target using Isothermal Titration Calorimetry (ITC). At temperature $T = 298\\ \\mathrm{K}$, the ITC experiment reports a binding enthalpy change $\\Delta H = -8\\ \\mathrm{kcal\\ mol^{-1}}$ and an independently determined standard Gibbs free energy change $\\Delta G = -10\\ \\mathrm{kcal\\ mol^{-1}}$. Using only fundamental thermodynamic relationships that connect $\\Delta G$, $\\Delta H$, and the entropy change $\\Delta S$, derive an expression for $\\Delta S$ in terms of $\\Delta G$, $\\Delta H$, and $T$, compute its value at the given temperature, and briefly conclude whether the binding is enthalpy-driven or entropy-driven based on the sign and relative magnitudes of the energetic contributions. Express the final numerical value of $\\Delta S$ in $\\mathrm{kcal\\ mol^{-1}\\ K^{-1}}$ and round your answer to $4$ significant figures.", "solution": "The problem is subjected to validation against the established criteria.\n\n### Step 1: Extract Givens\n- Temperature: $T = 298\\ \\mathrm{K}$\n- Enthalpy change of binding: $\\Delta H = -8\\ \\mathrm{kcal\\ mol^{-1}}$\n- Standard Gibbs free energy change of binding: $\\Delta G = -10\\ \\mathrm{kcal\\ mol^{-1}}$\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded, relying on the fundamental Gibbs free energy equation, a cornerstone of chemical thermodynamics. It is well-posed, providing all necessary and consistent data for a unique solution. The given values are physically realistic for biomolecular interactions. The problem is stated objectively and formally. It does not violate any of the specified invalidity criteria.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid**. A complete solution will be provided.\n\n***\n\nThe relationship between the standard Gibbs free energy change ($\\Delta G$), the enthalpy change ($\\Delta H$), and the entropy change ($\\Delta S$) for a process at constant temperature ($T$) is given by the fundamental thermodynamic equation:\n$$ \\Delta G = \\Delta H - T\\Delta S $$\nThis equation is central to understanding the spontaneity and energetic drivers of chemical and biological processes, including ligand-protein binding.\n\nThe first task is to derive an expression for the entropy change, $\\Delta S$, in terms of the other variables. We can algebraically rearrange the equation:\n1.  Start with the Gibbs free energy equation:\n    $$ \\Delta G = \\Delta H - T\\Delta S $$\n2.  Isolate the term containing $\\Delta S$ by adding $T\\Delta S$ to both sides and subtracting $\\Delta G$ from both sides:\n    $$ T\\Delta S = \\Delta H - \\Delta G $$\n3.  Divide by the absolute temperature $T$ (given as $T = 298\\ \\mathrm{K}$, which is non-zero) to solve for $\\Delta S$:\n    $$ \\Delta S = \\frac{\\Delta H - \\Delta G}{T} $$\nThis is the required expression for $\\Delta S$.\n\nThe second task is to compute the numerical value of $\\Delta S$ using the provided data:\n- $\\Delta H = -8\\ \\mathrm{kcal\\ mol^{-1}}$\n- $\\Delta G = -10\\ \\mathrm{kcal\\ mol^{-1}}$\n- $T = 298\\ \\mathrm{K}$\n\nSubstituting these values into the derived expression:\n$$ \\Delta S = \\frac{(-8\\ \\mathrm{kcal\\ mol^{-1}}) - (-10\\ \\mathrm{kcal\\ mol^{-1}})}{298\\ \\mathrm{K}} $$\n$$ \\Delta S = \\frac{-8 + 10}{298}\\ \\mathrm{kcal\\ mol^{-1}\\ K^{-1}} $$\n$$ \\Delta S = \\frac{2}{298}\\ \\mathrm{kcal\\ mol^{-1}\\ K^{-1}} $$\nPerforming the division:\n$$ \\Delta S \\approx 0.006711409...\\ \\mathrm{kcal\\ mol^{-1}\\ K^{-1}} $$\nRounding the result to $4$ significant figures, as requested, we obtain:\n$$ \\Delta S \\approx 0.006711\\ \\mathrm{kcal\\ mol^{-1}\\ K^{-1}} $$\n\nThe third task is to determine if the binding is enthalpy-driven or entropy-driven. A process is spontaneous if $\\Delta G  0$. In this case, $\\Delta G = -10\\ \\mathrm{kcal\\ mol^{-1}}$, so the binding is spontaneous. The spontaneity is driven by contributions from enthalpy ($\\Delta H$) and entropy ($-T\\Delta S$).\n\nThe enthalpic contribution to the free energy is $\\Delta H = -8\\ \\mathrm{kcal\\ mol^{-1}}$. Since this value is negative, the process is enthalpically favorable.\n\nThe entropic contribution to the free energy is $-T\\Delta S$. We have calculated $\\Delta S \\approx 0.006711\\ \\mathrm{kcal\\ mol^{-1}\\ K^{-1}}$. Since $\\Delta S$ is positive, the process is entropically favorable. Let's calculate the magnitude of this contribution:\n$$ -T\\Delta S = - (298\\ \\mathrm{K}) \\left( \\frac{2}{298}\\ \\mathrm{kcal\\ mol^{-1}\\ K^{-1}} \\right) = -2\\ \\mathrm{kcal\\ mol^{-1}} $$\nAs a check, $\\Delta G = \\Delta H - T\\Delta S = -8\\ \\mathrm{kcal\\ mol^{-1}} - (2\\ \\mathrm{kcal\\ mol^{-1}}) = -10\\ \\mathrm{kcal\\ mol^{-1}}$, which matches the given value.\n\nTo determine the primary driving force, we compare the absolute magnitudes of the enthalpic and entropic contributions to $\\Delta G$:\n- Magnitude of enthalpic contribution: $|\\Delta H| = |-8\\ \\mathrm{kcal\\ mol^{-1}}| = 8\\ \\mathrm{kcal\\ mol^{-1}}$\n- Magnitude of entropic contribution: $|-T\\Delta S| = |-2\\ \\mathrm{kcal\\ mol^{-1}}| = 2\\ \\mathrm{kcal\\ mol^{-1}}$\n\nSince $|\\Delta H| > |-T\\Delta S|$ ($8\\ \\mathrm{kcal\\ mol^{-1}} > 2\\ \\mathrm{kcal\\ mol^{-1}}$), the favorable enthalpy change is the dominant contributor to the overall negative Gibbs free energy. Therefore, the binding is classified as **enthalpy-driven**.", "answer": "$$\\boxed{0.006711}$$", "id": "4985168"}, {"introduction": "A potent drug is useless if it cannot reach its target in the body. For oral drugs, this journey involves crossing cellular membranes, a process heavily influenced by the drug's physicochemical properties. This practice explores the critical relationship between a drug's ionization state and its ability to passively diffuse across membranes, governed by its $pK_a$ and the local $pH$. By applying principles derived from mass action, you will quantify the fraction of a drug available for absorption, a vital step in predicting oral bioavailability [@problem_id:4985154].", "problem": "A medicinal chemist is optimizing a monoprotic tertiary amine intended for oral absorption. The conjugate acid of the amine has an acid dissociation constant with $pK_{a}=8.5$. In an aqueous environment at physiological potential of hydrogen ($pH=7.4$), assume ideal activity (activity coefficients equal to unity), a single relevant protonation site, and that only the neutral (unionized) base diffuses passively across a lipid bilayer.\n\nStarting strictly from the law of mass action and the definition of the acid dissociation constant for the protonation equilibrium of a base,\n$$\\mathrm{BH}^{+} \\rightleftharpoons \\mathrm{B} + \\mathrm{H}^{+},$$\nderive an expression for the fraction of the total drug that is present as unionized base $\\mathrm{B}$ at a given $pH$ in terms of $pH$ and $pK_{a}$, and then compute its value at $pH=7.4$ for $pK_{a}=8.5$. Briefly, based on this fraction, state whether passive membrane permeability mediated by the neutral species is expected to be limited or facilitated under these conditions, and why, using principles of physicochemical partitioning that relate ionization to membrane permeability.\n\nRound your numerical fraction to four significant figures and express it as a unitless decimal (do not use a percentage sign).", "solution": "The problem requires the derivation of an expression for the fraction of an amine drug present in its unionized (neutral base) form, $\\mathrm{B}$, as a function of $pH$ and the $pK_{a}$ of its conjugate acid, $\\mathrm{BH}^{+}$. Subsequently, this fraction is to be calculated for the given values, and an interpretation regarding membrane permeability is to be provided. The derivation must start from the law of mass action for the specified equilibrium.\n\nStep 1: Derivation of the expression for the fraction of unionized base, $f_{\\mathrm{B}}$.\n\nThe equilibrium for the dissociation of the conjugate acid, $\\mathrm{BH}^{+}$, is given as:\n$$ \\mathrm{BH}^{+} \\rightleftharpoons \\mathrm{B} + \\mathrm{H}^{+} $$\nThe law of mass action for this equilibrium defines the acid dissociation constant, $K_{a}$. Assuming ideal activity (activity coefficients are unity), we can use molar concentrations:\n$$ K_{a} = \\frac{[\\mathrm{B}][\\mathrm{H}^{+}]}{[\\mathrm{BH}^{+}]} $$\nwhere $[\\mathrm{B}]$, $[\\mathrm{H}^{+}]$, and $[\\mathrm{BH}^{+}]$ are the molar concentrations of the neutral base, protons, and the protonated base (conjugate acid), respectively.\n\nThe fraction of the drug in the unionized base form, which we denote as $f_{\\mathrm{B}}$, is the concentration of the base, $[\\mathrm{B}]$, divided by the total concentration of the drug, $C_{total}$. The total concentration is the sum of the concentrations of the unionized and ionized forms:\n$$ C_{total} = [\\mathrm{B}] + [\\mathrm{BH}^{+}] $$\nTherefore, the fraction of unionized base is:\n$$ f_{\\mathrm{B}} = \\frac{[\\mathrm{B}]}{C_{total}} = \\frac{[\\mathrm{B}]}{[\\mathrm{B}] + [\\mathrm{BH}^{+}]} $$\nTo express $f_{\\mathrm{B}}$ in terms of measurable quantities, we first rearrange the $K_{a}$ expression to solve for $[\\mathrm{BH}^{+}]$:\n$$ [\\mathrm{BH}^{+}] = \\frac{[\\mathrm{B}][\\mathrm{H}^{+}]}{K_{a}} $$\nNow, we substitute this expression for $[\\mathrm{BH}^{+}]$ into the equation for $f_{\\mathrm{B}}$:\n$$ f_{\\mathrm{B}} = \\frac{[\\mathrm{B}]}{[\\mathrm{B}] + \\frac{[\\mathrm{B}][\\mathrm{H}^{+}]}{K_{a}}} $$\nThe term $[\\mathrm{B}]$ is common to all terms in the numerator and denominator, so it can be canceled out:\n$$ f_{\\mathrm{B}} = \\frac{1}{1 + \\frac{[\\mathrm{H}^{+}]}{K_{a}}} $$\nThe problem requires the expression in terms of $pH$ and $pK_{a}$. We use the standard definitions:\n$$ pH = -\\log_{10}([\\mathrm{H}^{+}]) \\implies [\\mathrm{H}^{+}] = 10^{-pH} $$\n$$ pK_{a} = -\\log_{10}(K_{a}) \\implies K_{a} = 10^{-pK_{a}} $$\nSubstituting these expressions for $[\\mathrm{H}^{+}]$ and $K_{a}$ into the equation for $f_{\\mathrm{B}}$:\n$$ f_{\\mathrm{B}} = \\frac{1}{1 + \\frac{10^{-pH}}{10^{-pK_{a}}}} $$\nUsing the property of exponents, $\\frac{10^{a}}{10^{b}} = 10^{a-b}$, we simplify the denominator:\n$$ f_{\\mathrm{B}} = \\frac{1}{1 + 10^{-pH - (-pK_{a})}} = \\frac{1}{1 + 10^{pK_{a} - pH}} $$\nThis is the desired derived expression for the fraction of the drug present as the unionized base.\n\nStep 2: Calculation of the numerical value for $f_{\\mathrm{B}}$.\n\nThe problem provides the values $pK_{a} = 8.5$ and $pH = 7.4$. We substitute these into the derived expression:\n$$ f_{\\mathrm{B}} = \\frac{1}{1 + 10^{8.5 - 7.4}} $$\n$$ f_{\\mathrm{B}} = \\frac{1}{1 + 10^{1.1}} $$\nCalculating the value of $10^{1.1}$:\n$$ 10^{1.1} \\approx 12.589254 $$\nNow, we calculate $f_{\\mathrm{B}}$:\n$$ f_{\\mathrm{B}} = \\frac{1}{1 + 12.589254} = \\frac{1}{13.589254} \\approx 0.0735879 $$\nRounding the result to four significant figures, as requested:\n$$ f_{\\mathrm{B}} \\approx 0.07359 $$\n\nStep 3: Interpretation of the result.\n\nThe calculated fraction of the neutral base, $f_{\\mathrm{B}} \\approx 0.07359$, indicates that at a physiological $pH$ of $7.4$, approximately $7.36\\%$ of the drug is in its unionized, neutral form ($\\mathrm{B}$). The remaining fraction, $1 - f_{\\mathrm{B}} \\approx 0.9264$ or about $92.6\\%$, exists as the protonated, charged cation ($\\mathrm{BH}^{+}$).\n\nAccording to the principles of physicochemical partitioning (often simplified as the pH-partition hypothesis), only the neutral, lipophilic form of a drug can readily diffuse across lipid bilayer membranes, such as the gastrointestinal epithelium. The ionized form is highly polar and hydrophilic, and its passage through the lipid core of the membrane is energetically unfavorable.\n\nGiven that a very small fraction ($~7.4\\%$) of the total drug concentration is present as the permeable neutral species at $pH=7.4$, the rate of passive membrane diffusion will be proportionally low. Therefore, passive membrane permeability is expected to be **limited** under these conditions. The extensive ionization of the amine at physiological $pH$ is a significant barrier to its absorption by passive diffusion. This is a common challenge for basic drugs, as the equilibrium $ \\mathrm{BH}^{+} \\rightleftharpoons \\mathrm{B} + \\mathrm{H}^{+} $ is shifted to the left when the $pH$ is below the $pK_{a}$, favoring the charged species.", "answer": "$$\n\\boxed{0.07359}\n$$", "id": "4985154"}]}